Company intelligence / Profile preview

Parallel Fluidics

Boston, Massachusetts, United States

Ownership: Private
Employees: ~23
Development stage: Other

Overview

Parallel Fluidics provides production-grade microfluidic devices with the industry's fastest turnaround time, reducing prototype development from 3-4 weeks to 2-3 days. The company serves academic institutions, venture-backed startups, and large biotech companies across diagnostics, drug discovery, precision medicine, sequencing, and cell therapy applications.

Therapeutic areas: OncologyOtherHematology
Modalities: Device
Industry: Consumable Medical Devices

Partnerships

Overture Life

Beyond the preview

Go deeper on Parallel Fluidics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parallel Fluidics.

Explore the full profile